Therapeutic Hypothermia Systems Market

The global therapeutic hypothermia systems market is projected to reach USD 396 million by 2028 from USD 291 million in 2023, at a CAGR of 6.3% during the forecast period. Growth in this market is attributed to the growing population and increase in the prevalence of chronic and infectious diseases, the growing number of surgical procedures, and the increasing adoption of minimally invasive cooling methods.

The therapeutic hypothermia systems market is competitive and is dominated by various players. The major players operating in this market are ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), and Stryker Corporation (US). These include partnerships, product launches, contracts, mergers and acquisitions, and new product development activities to further expand their presence in the therapeutic hypothermia systems market.

To know about the assumptions considered for the study download the pdf brochure

BECTON, DICKINSON AND COMPANY (US)

BD (US) will be a leading player in the therapeutic hypothermia systems market in 2022. In the therapeutic hypothermia systems market, the company has a strong presence in 190 countries on all continents and seeks to enhance its geographical presence by strengthening its business operations in emerging markets. The company sells its products to a geographically diverse customer base.

ZOLL MEDICAL CORPORATION (US)

ZOLL Medical Corporation (Japan) held the second position in the therapeutic hypothermia systems market in 2022. The company’s strong position in the market can be primarily attributed to its product portfolio. The company offers a wide range of therapeutic hypothermia products ranging from systems to catheters. Besides, the company also has a strong geographic presence, which is the main factor in the company’s strong customer base. Thermo has employed various strategies to strengthen the company’s position in the market. For instance, in 2023, the company signed an agreement with BrainCool, a medical device company specializing in therapeutic hypothermia systems solutions, for the exclusive distribution of the BrainCool System/IQool System and the IQool System Pads in the US and key markets in Europe.

STRYKER CORPORATION (US)

Stryker Corporation (US) held the third position in the therapeutic hypothermia systems market in 2022. The company operates through its MedSurg and Neurotechnology segment in the patient temperature management business, which addresses the needs of inducing mild hypothermia therapy for post-cardiac arrest, neonatal hypoxic-ischemic encephalopathy (HIE), and post-traumatic brain injury (TBI). The company sells its products to a geographically diverse customer base. It continues to improve its global supply chain, which helps ensure continued access to its products. This is expected to help the company retain its position in the market.

Related Reports:

Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]